Xanthohumol, a prenylated chalcone from hops, modulates hepatic expression of genes involved in thyroid hormone distribution and metabolism

Molecular Nutrition and Food Research

Volumn 54, Issue SUPPL. 2, 2010, Pages

  Radović, Branislav ^a,e   Hussong, Ragna ^b   Gerhäuser, Clarissa ^b   Meinl, Walter ^c   Frank, Norbert ^b   Becker, Hans ^d   Köhrle, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Constitutive androstane receptor; Thyroid hormone; Thyroxine binding globulin; Transthyretin; Xanthohumol

Indexed keywords

FLAVONOID; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE I; MESSENGER RNA; PREALBUMIN; PROPIOPHENONE DERIVATIVE; THYROID HORMONE; THYROXINE; THYROXINE BINDING GLOBULIN; XANTHOHUMOL;

ANIMAL; ARTICLE; BINDING COMPETITION; BIOTRANSFORMATION; BLOOD; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLOWER; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMULUS; KINETICS; LIVER; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BINDING, COMPETITIVE; BIOTRANSFORMATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; FLOWERS; GENE EXPRESSION REGULATION; HUMANS; HUMULUS; IODIDE PEROXIDASE; KINETICS; LIVER; PREALBUMIN; PROPIOPHENONES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THYROID HORMONES; THYROXINE; THYROXINE-BINDING GLOBULIN;

HUMULUS; RATTUS;

EID: 79251473706     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900489     Document Type: Article

References (72)

1. Chadwick, L. R., Pauli, G. F., Farnsworth, N. R., The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine 2006, 13, 119-131.
2. Coldham, N. G., Sauer, M. J., Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem. Toxicol. 2001, 39, 1211-1224.
3. Heyerick, A., Vervarcke, S., Depypere, H., Bracke, M., De Keukeleire, D., A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 2006, 54, 164-175.
4. Bolca, S., Possemiers, S., Maervoet, V., Huybrechts, I. et al., Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women. Br. J. Nutr. 2007, 98, 950-959.
5. Gerhauser, C., Alt, A., Heiss, E., Gamal-Eldeen, A. et al., Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 2002, 1, 959-969.
6. Gerhauser, C., Beer constituents as potential cancer chemopreventive agents. Eur. J. Cancer 2005, 41, 1941-1954.
7. Strathmann, J., Bertl, E., Hussong, R., Klimo, K. et al., Xanthohumol from hops prevents hormone-dependent tumourigenesis in vitro and in vivo. Acta horticulturae 2009, 848, 179-190.
8. Casaschi, A., Maiyoh, G. K., Rubio, B. K., Li, R. W. et al., The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. J. Nutr. 2004, 134, 1340-1346.
9. Nozawa, H., Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochem. Biophys. Res. Commun. 2005, 336, 754-761.
10. Doerge, D. R., Chang, H. C., Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 777, 269-279.
11. Divi, R. L., Chang, H. C., Doerge, D. R., Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem. Pharmacol. 1997, 54, 1087-1096.
12. Chang, H. C., Doerge, D. R., Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol. Appl. Pharmacol. 2000, 168, 244-252.
13. Radovic, B., Schmutzler, C., Kohrle, J., Xanthohumol stimulates iodide uptake in rat thyroid-derived FRTL-5 cells. Mol. Nutr. Food. Res. 2005, 49, 832-836.
14. Young, R. A., Braverman, L. E., Rajatanavin, R., Low protein-high carbohydrate diet induces alterations in the serum thyronine-binding proteins in the rat. Endocrinology 1982, 110, 1607-1612.
15. Kohrle, J., Fang, S. L., Yang, Y., Irmscher, K. et al., Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinology 1989, 125, 532-537.
16. Radovic, B., Mentrup, B., Kohrle, J., Genistein and other soya isoflavones are potent ligands for transthyretin in serum and cerebrospinal fluid. Br. J. Nutr. 2006, 95, 1171-1176.
17. Richardson, S. J., Cell and molecular biology of transthyretin and thyroid hormones. Int. Rev. Cytol. 2007, 258, 137-193.
18. Visser, T. J., Pathways of thyroid hormone metabolism. Acta. Med. Austriaca 1996, 23, 10-16.
19. Kohrle, J., Environment and endocrinology: the case of thyroidology. Ann. Endocrinol. (Paris) 2008, 69, 116-122.
20. Burchell, B., Coughtrie, M. W., UDP-glucuronosyltransferases. Pharmacol. Ther. 1989, 43, 261-289.
21. de Herder, W. W., Bonthuis, F., Rutgers, M., Otten, M. H. et al., Effects of inhibition of type I iodothyronine deiodinase and phenol sulfotransferase on the biliary clearance of triiodothyronine in rats. Endocrinology 1988, 122, 153-157.
22. Mol, J. A., Visser, T. J., Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology 1985, 117, 8-12.
23. Visser, T. J., Kaptein, E., Gijzel, A. L., de Herder, W. W. et al., Glucuronidation of thyroid hormone by human bilirubin and phenol UDP-glucuronyltransferase isoenzymes. FEBS Lett. 1993, 324, 358-360.
24. Kaptein, E., van Haasteren, G. A., Linkels, E., de Greef, W. J., Visser, T. J., Characterization of iodothyronine sulfotransferase activity in rat liver. Endocrinology 1997, 138, 5136-5143.
25. Visser, T. J., Kaptein, E., Glatt, H., Bartsch, I. et al., Characterization of thyroid hormone sulfotransferases. Chem. Biol. Interact. 1998, 109, 279-291.
26. Forman, B. M., Tzameli, I., Choi, H. S., Chen, J. et al., Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 1998, 395, 612-615.
27. Honkakoski, P., Zelko, I., Sueyoshi, T., Negishi, M., The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell Biol. 1998, 18, 5652-5658.
28. Yoshinari, K., Sueyoshi, T., Moore, R., Negishi, M., Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYB2B1 gene by phenobarbital in rat livers. Mol. Pharmacol. 2001, 59, 278-284.
29. Wei, P., Zhang, J., Dowhan, D. H., Han, Y., Moore, D. D., Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J. 2002, 2, 117-126.
30. Maglich, J. M., Watson, J., McMillen, P. J., Goodwin, B. et al., The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J. Biol. Chem. 2004, 279, 19832-19838.
31. Kakizaki, S., Yamazaki, Y., Takizawa, D., Negishi, M., New insights on the xenobiotic-sensing nuclear receptors in liver diseases - CAR and PXR. Curr. Drug Metab. 2008, 9, 614-621.
32. Qatanani, M., Zhang, J., Moore, D. D., Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology 2005, 146, 995-1002.
33. Roth, A., Looser, R., Kaufmann, M., Blattler, S. M. et al., Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol. Pharmacol. 2008, 73, 1282-1289.
34. Moreau, A., Vilarem, M. J., Maurel, P., Pascussi, J. M., Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol. Pharm. 2008, 5, 35-41.
35. Somack, R., Andrea, T. A., Jorgensen, E. C., Thyroid hormone binding to human serum prealbumin and rat liver nuclear receptor: kinetics, contribution of the hormone phenolic hydroxyl group, and accommodation of hormone side-chain bulk. Biochemistry 1982, 21, 163-170.
36. Hussong, R., Frank, N., Knauft, J., Ittrich, C. et al., A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats. Mol. Nutr. Food Res. 2005, 49, 861-867.
37. Schmutzler, C., Bacinski, A., Gotthardt, I., Huhne, K. et al., The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase. Endocrinology 2007, 148, 2835-2844.
38. Visser, T. J., Leonard, J. L., Kaplan, M. M., Larsen, P. R., Kinetic evidence suggesting two mechanisms for iodothyronine 5'-deiodination in rat cerebral cortex. Proc. Natl. Acad Sci. USA 1982, 79, 5080-5084.
39. Findlay, K. A., Kaptein, E., Visser, T. J., Burchell, B., Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J. Clin. Endocrinol. Metab. 2000, 85, 2879-2883.
40. Vanhoecke, B. W., Delporte, F., Van Braeckel, E., Heyerick, A. et al., A safety study of oral tangeretin and xanthohumol administration to laboratory mice. In Vivo 2005, 19, 103-107.
41. Auf'mkolk, M., Koehrle, J., Hesch, R. D., Cody, V., Inhibition of rat liver iodothyronine deiodinase, Interaction of aurones with the iodothyronine ligand-binding site. J. Biol. Chem. 1986, 261, 11623-11630.
42. Maia, F., Almeida Mdo, R., Gales, L., Kijjoa, A. et al., The binding of xanthone derivatives to transthyretin. Biochem. Pharmacol. 2005, 70, 1861-1869.
43. Nicoloff, J. T., Low, J. C., Dussault, J. H., Fisher, D. A., Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. J. Clin. Invest. 1972, 51, 473-483.
44. Savu, L., Vranckx, R., Maya, M., Nunez, E. A., Binding activities of thyroxine binding globulin versus thyroxine binding prealbumin in rat sera: differential modulation by thyroid hormone ligands, oleic acid and pharmacological drugs. Biochem. Biophys. Res. Commun. 1989, 159, 919-926.
45. Savu, L., Vranckx, R., Maya, M., Nunez, E. A., A thyroxine binding globulin (TBG)-like protein in the sera of developing and adult rats. Biochem. Biophys. Res. Commun. 1987, 148, 1165-1173.
46. Schreiber, G. in: Putnam, F. W. (Ed.), The Plasma Proteins, Academic Press, New York 1987, pp. 293-363.
47. Snyder, S. M., Cavalieri, R. R., Goldfine, I. D., Ingbar, S. H., Jorgensen, E. C., Binding of thyroid hormones and their analogues to thyroxine-binding globulin in human serum. J. Biol. Chem. 1976, 251, 6489-6494.
48. Kim, M. S., Shigenaga, J., Moser, A., Grunfeld, C., Feingold, K. R., Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E731-E738.
49. Refetoff, S., Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4, 1.
50. Ruefer, C. E., Gerhauser, C., Frank, N., Becker, H., Kulling, S. E., In vitro phase II metabolism of xanthohumol by human UDP-glucuronosyltransferases and sulfotransferases. Mol. Nutr. Food Res. 2005, 49, 851-856.
51. Visser, T. J., Kaptein, E., Harpur, E. S., Differential expression and ciprofibrate induction of hepatic UDP-glucuronyltransferases for thyroxine and triiodothyronine in Fischer rats. Biochem. Pharmacol. 1991, 42, 444-446.
52. Beetstra, J. B., van Engelen, J. G., Karels, P., van der Hoek, H. J. et al., Thyroxine and 3, 3', 5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology 1991, 128, 741-746.
53. Masmoudi, T., Hihi, A. K., Vazquez, M., Artur, Y. et al., Transcriptional regulation by triiodothyronine of the UDP-glucuronosyltransferase family 1 gene complex in rat liver, Comparison with induction by 3-methylcholanthrene. J. Biol. Chem. 1997, 272, 17171-17175.
54. Li, Y. Q., Prentice, D. A., Howard, M. L., Mashford, M. L., Desmond, P. V., The effect of hormones on the expression of five isoforms of UDP-glucuronosyltransferase in primary cultures of rat hepatocytes. Pharm. Res. 1999, 16, 191-197.
55. Haberkorn, V., Heydel, J. M., Mounie, J., Artur, Y., Goudonnet, H., Influence of vitamin A status on the regulation of uridine (5'-)diphosphate-glucuronosyltransferase (UGT) 1A1 and UGT1A6 expression by L-triiodothyronine. Br. J. Nutr. 2001, 85, 289-297.
56. Haberkorn, V., Heydel, J. M., Mounie, J., Artur, Y., Goudonnet, H., Vitamin A modulates the effects of thyroid hormone on UDP-glucuronosyltransferase expression and activity in rat liver. Mol. Cell Endocrinol. 2002, 190, 167-175.
57. Runge-Morris, M., Rose, K., Falany, C. N., Kocarek, T. A., Differential regulation of individual sulfotransferase isoforms by phenobarbital in male rat liver. Drug. Metab. Dispos. 1998, 26, 795-801.
58. Henderson, M. C., Miranda, C. L., Stevens, J. F., Deinzer, M. L., Buhler, D. R., In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 2000, 30, 235-251.
59. Monteiro, R., Becker, H., Azevedo, I., Calhau, C., Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J. Agric. Food Chem. 2006, 54, 2938-2943.
60. Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M. et al., Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev. 2000, 14, 3014-3023.
61. Wei, Y., Van Nhieu, J. T., Prigent, S., Srivatanakul, P. et al., Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology 2002, 36, 692-701.
62. Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D. et al., Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol. Pharmacol. 2002, 62, 638-646.
63. Xiong, H., Yoshinari, K., Brouwer, K. L., Negishi, M., Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metab. Dispos. 2002, 30, 918-923.
64. Huang, W., Zhang, J., Chua, S. S., Qatanani, M. et al., Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. USA 2003, 100, 4156-4161.
65. Assem, M., Schuetz, E. G., Leggas, M., Sun, D. et al., Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J. Biol. Chem. 2004, 279, 22250-22257.
66. Numazawa, S., Shindo, S., Maruyama, K., Chibana, F. et al., Impaired nuclear translocation of CAR in hepatic preneoplastic lesions: association with an attenuated CYP2B induction by phenobarbital. FEBS Lett. 2005, 579, 3560-3564.
67. Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y. et al., Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. 2002, 61, 1-6.
68. Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R. et al., Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell Biol. 1999, 19, 6318-6322.
69. Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., Moore, D. D., The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000, 407, 920-923.
70. Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., Maronpot, R. R., The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 2004, 64, 7197-7200.
71. Dietz, B. M., Kang, Y. H., Liu, G., Eggler, A. L. et al., Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase. Chem. Res. Toxicol. 2005, 18, 1296-1305.
72. Liu, G., Eggler, A. L., Dietz, B. M., Mesecar, A. D. et al., Screening method for the discovery of potential cancer chemoprevention agents based on mass spectrometric detection of alkylated Keap1. Anal. Chem. 2005, 77, 6407-6414.